NEW YORK, July 31, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Optimer Pharmaceuticals, Inc. ("Optimer" or the "Company") (NASDAQ: OPTR) (ISIN: US68401H1041) (CUSIP: 68401H104) concerning the proposed acquisition of Optimer by Cubist Pharmaceuticals, Inc. in a transaction valued at $801 million.
The investigation concerns whether the Optimer directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Optimer shareholders will be entitled to receive $10.75 per share in cash for each share of Optimer common stock. In addition to the upfront cash payment, each stockholder of Optimer will receive a Contingent Value Right, which is expected to be publicly traded, entitling the holder to receive an additional one-time cash payment of up to $5.00 for each share they own if certain net sales of DIFICID®(fidaxomicin) are achieved. However, the price to Revenue and Book Value multiples are below the averages of comparable transactions and at least one analyst has set a target price of $16.00 per share for Optimer common stock.
Optimer shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at firstname.lastname@example.org or 212-661-1100 or 888-476-6529, ext. 237.
The firm is also investigating actions on behalf of shareholders for the following companies: Hilltop Community Bancorp, Inc., Dole Food Company, Inc., and Cooper Tire & Rubber Company.The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com. CONTACT: Robert Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP212-661-1100 ext. 237 email@example.com SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP